Skip to main content

Advertisement

SpringerLink
Log in

Perioperative Intra-Arterial and Systemic Chemotherapy for Pancreatic Cancer

  • Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Even after curative resection of pancreatic cancer, there is a high probability of systemic recurrence. This indicates that subclinical metastases are already present at the time of operation. The purpose of this study was to assess the feasibility and outcomes of patients who received a novel multimodality therapy combining pancreatic resection and intraoperative radiation therapy (IORT) with pre- and postoperative chemotherapy for pancreatic cancer.

Methods

For eligible patients with pancreatic cancer, 5-FU was administered at a dose of 125 mg/m2/day on days 1–5 every week as a continuous pancreatic and hepatic arterial infusion, and gemcitabine was infused intravenously at a dose of 800 mg/m2 per day once per week for 2 weeks for preoperative chemotherapy. Pancreatic resection combined with IORT was performed 1 week after preoperative chemotherapy. Postoperative chemotherapy was performed in the same way as preoperative chemotherapy. We performed an intention-to-treat analysis for all enrolled patients.

Results

This study enrolled 44 patients. The most common toxicities were hematological and gastrointestinal events. Grade 3/4 hematological toxicities were observed during preoperative chemotherapy, although there were no grade 3/4 nonhematological events. Postoperative chemotherapy-related toxicities were more critical and frequent than preoperative ones. There were no pre- or postoperative chemotherapy-associated deaths. Median overall survival was 36.5 months with 30.5% overall 5-year survival.

Conclusions

This multimodality therapy is feasible and promises to contribute to survival. It should be evaluated in a phase III setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995;82:111–5.

    Article  PubMed  CAS  Google Scholar 

  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    Article  PubMed  Google Scholar 

  3. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RE, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 1990;66:56–61.

    Article  PubMed  CAS  Google Scholar 

  4. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg. 1997;21:195–200.

    Article  PubMed  CAS  Google Scholar 

  5. Takamori H, Hiraoka T, Kanemitsu K, Tsuji T. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer. Hepato-Gastroenterol. 2004;51:1500–3.

    Google Scholar 

  6. Hiraoka T, Uchino R, Kanemitsu K, et al. Combination of intraoperative radiation with resection of cancer of the pancreas. Int J Pancreatol. 1990;7:201–7.

    PubMed  CAS  Google Scholar 

  7. Takamori H, Kanemitsu K, Tsuji T, et al. 5-Fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer. Pancreas. 2005;30:223–6.

    Article  PubMed  CAS  Google Scholar 

  8. Takamori H, Ikeda O, Kanemitsu K, et al. Preoperative detection of liver metastases secondary to pancreatic cancer. Utility of combined helical computed tomography during arterial portography with biphasic computed tomography-assisted hepatic arteriography. Pancreas. 2004;29:188–92.

    Article  PubMed  Google Scholar 

  9. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.

    Article  PubMed  Google Scholar 

  10. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335–9.

    PubMed  CAS  Google Scholar 

  11. Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. Oncologist. 2002;7:34–45.

    Article  PubMed  Google Scholar 

  12. Pisters PW, Wolff RA, Janjan NA, et al. Preoperative paclitaxel and concurrent rapid fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol. 2002;20:2537–44.

    Article  PubMed  CAS  Google Scholar 

  13. Z’graggen K, Centeno BA, Fernandez-del Castillo C, Jimenez RE, Werner J, Warshaw AL. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery. 2001;129:537–46.

    Article  PubMed  Google Scholar 

  14. Sohn TA, Yeo CJ, Cameron JT, et al. Resected adenocarcinoma of the pancreas–616 patients: results, outcomes, and prognosis indicators. J Gastrointest Surg. 2000;4:567–79.

    Article  PubMed  CAS  Google Scholar 

  15. Frederick WAI, Wolff RA, Crane CH. Preoperative (neoadjuvant) therapy for resectable adenocarcinoma of the pancreas. In: Evans DB, Pisters PWT, Abbruzzese JL, Pollock RE, editors. MD Anderson Solid Tumor Oncology Series. New York: Springer; 2001. p. 243–54.

  16. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg. 1989;76:545–8.

    Article  PubMed  CAS  Google Scholar 

  17. Ackermann NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery. 1974;75:589–96.

    Google Scholar 

  18. Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg. 1994;168:361–4.

    Article  PubMed  CAS  Google Scholar 

  19. Beger HG, Gansauge F, Büchler MW, Link KH. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg. 1999; 23:946–949.

    Article  PubMed  CAS  Google Scholar 

  20. Breslin TM, Hess KR, Harbison DB, et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol. 2001;8:123–32.

    Article  PubMed  CAS  Google Scholar 

  21. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15:928–37.

    PubMed  CAS  Google Scholar 

  22. Tepper JE, Nardi G, Suit H. Carcinoma of the pancreas: review of MGH experience from 1963–1973. Analysis of surgical failure and implications for radiation therapy. Cancer. 1976;37:1519–25.

    Article  PubMed  CAS  Google Scholar 

  23. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer. 1993;72:2118–23.

    Article  PubMed  CAS  Google Scholar 

  24. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 1991;21:1137–43.

    Article  PubMed  CAS  Google Scholar 

  25. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. A randomized controlled trial. JAMA. 2007;297:267–77.

    Article  PubMed  CAS  Google Scholar 

  26. Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreas. J Clin Oncol. 2008;26:3496–502.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Hiroshi Takamori MD, Keiichiro Kanemitsu MD, Masahiko Hirota MD, Hiroshi Tanaka MD, Toru Beppu MD & Hideo Baba MD

  2. Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Osamu Ikeda MD & Yasuyuki Yamashita MD

  3. Department of Radiation Oncology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Natsuo Oya MD

Authors
  1. Hiroshi Takamori MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keiichiro Kanemitsu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahiko Hirota MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Osamu Ikeda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Tanaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toru Beppu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasuyuki Yamashita MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Natsuo Oya MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hideo Baba MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Takamori MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takamori, H., Kanemitsu, K., Hirota, M. et al. Perioperative Intra-Arterial and Systemic Chemotherapy for Pancreatic Cancer. Ann Surg Oncol 18, 1110–1115 (2011). https://doi.org/10.1245/s10434-010-1384-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1384-6

Keywords

Search

Navigation